DE69331086D1 - Protein des Cadherin-Typs aus Knochen und Verfahren zur Herstellung - Google Patents

Protein des Cadherin-Typs aus Knochen und Verfahren zur Herstellung

Info

Publication number
DE69331086D1
DE69331086D1 DE69331086T DE69331086T DE69331086D1 DE 69331086 D1 DE69331086 D1 DE 69331086D1 DE 69331086 T DE69331086 T DE 69331086T DE 69331086 T DE69331086 T DE 69331086T DE 69331086 D1 DE69331086 D1 DE 69331086D1
Authority
DE
Germany
Prior art keywords
bone
osf
protein
cadherin
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69331086T
Other languages
English (en)
Other versions
DE69331086T2 (de
Inventor
Sunao Takeshita
Makoto Okazaki
Shinji Kawai
Atsushi Tsujimura
Dr Amann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of DE69331086D1 publication Critical patent/DE69331086D1/de
Publication of DE69331086T2 publication Critical patent/DE69331086T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69331086T 1992-08-28 1993-08-25 Protein des Cadherin-Typs aus Knochen und Verfahren zur Herstellung Expired - Fee Related DE69331086T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23002892 1992-08-28

Publications (2)

Publication Number Publication Date
DE69331086D1 true DE69331086D1 (de) 2001-12-13
DE69331086T2 DE69331086T2 (de) 2002-06-06

Family

ID=16901442

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331086T Expired - Fee Related DE69331086T2 (de) 1992-08-28 1993-08-25 Protein des Cadherin-Typs aus Knochen und Verfahren zur Herstellung

Country Status (10)

Country Link
US (1) US5869638A (de)
EP (1) EP0585801B1 (de)
JP (1) JP3560252B2 (de)
AT (1) ATE208420T1 (de)
AU (1) AU663216B2 (de)
CA (1) CA2104997A1 (de)
DE (1) DE69331086T2 (de)
DK (1) DK0585801T3 (de)
ES (1) ES2167322T3 (de)
PT (1) PT585801E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06121678A (ja) * 1992-08-28 1994-05-06 Hoechst Japan Ltd 骨関連サルファターゼ様タンパク質およびその製造法
EP0832195B1 (de) 1995-06-07 2005-11-09 co.don Aktiengesellschaft Verfahren zur osteoporosediagnose und zur testung potentieller osteoporose-therapeutika unter verwendung von standardisierten, primären osteoblastenzellkulturen aus osteoporotischen patienten
EP1023445B1 (de) 1997-10-15 2005-08-17 Pharis Biotec GmbH Cadherin derived growth factor und seine verwendung
US7481999B2 (en) 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US6472367B1 (en) * 1998-05-05 2002-10-29 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin mediated cell adhesion
WO2001090145A2 (en) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 57805, a human cadherin family member and uses thereof
ES2570855T3 (es) * 2005-09-28 2016-05-20 Univ California Péptidos de unión al calcio
JP5886283B2 (ja) * 2010-07-15 2016-03-16 アドヘロン セラピューティクス，インコーポレイテッド カドヘリン−１１のｅｃ１ドメインを標的とするヒト化抗体ならびに関連組成物および方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT98109A (pt) * 1990-06-29 1992-07-31 Hoechst Japan Processo recombinante para a preparacao duma nova proteina
WO1993000353A1 (en) * 1991-06-20 1993-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product
WO1993021302A1 (en) * 1992-04-17 1993-10-28 Doheny Eye Institute Cadherin materials and methods
JP3472587B2 (ja) * 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
DE4228839A1 (de) * 1992-08-29 1994-03-03 Behringwerke Ag Verfahren zum Nachweis und zur Bestimmung von Mediatoren

Also Published As

Publication number Publication date
JPH06122700A (ja) 1994-05-06
EP0585801B1 (de) 2001-11-07
AU663216B2 (en) 1995-09-28
AU4492293A (en) 1994-03-03
ES2167322T3 (es) 2002-05-16
DK0585801T3 (da) 2002-03-11
EP0585801A2 (de) 1994-03-09
DE69331086T2 (de) 2002-06-06
PT585801E (pt) 2002-04-29
JP3560252B2 (ja) 2004-09-02
CA2104997A1 (en) 1994-03-01
EP0585801A3 (en) 1994-06-29
ATE208420T1 (de) 2001-11-15
US5869638A (en) 1999-02-09

Similar Documents

Publication Publication Date Title
ATE298800T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
EA200300845A1 (ru) Модифицированные антитела и способы применения
Hernigou et al. History of internal fixation (part 1): early developments with wires and plates before World War II
ATE269102T1 (de) Verwendung von fibroblastwachstumsfaktoren zur stimulierung des knochenwachstums
DE69634748D1 (de) Verwendung von fibroblasten-wachstumsfaktor analogen zur stimulation des knochenwachstums
ATE493433T1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
ATE130365T1 (de) Bakterien transformiert mit expressionsplasmiden, die für den menschlichen neurothrophen wimper faktor (h-cntf) kodieren, ihre verwendung in der herstellung von h-cntf, antikörper gegen h-cntf und die anwendung von h-cntf in medizischer behandlung.
ATE192495T1 (de) Carboxypeptidase-ähnliches protein aus knochen und verfahren zur dessen herstellung
DE69331086D1 (de) Protein des Cadherin-Typs aus Knochen und Verfahren zur Herstellung
DE69929787D1 (de) Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps
ATE167232T1 (de) Protein mit knochenbildungs-eigenschaften und verfahren zu seiner herstellung
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE165008T1 (de) Methode zur behandlung intestinaler krankheiten
ATE111455T1 (de) 3-substituierte 1,2,3,4-oxatriazol-5- iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.
ATE353019T1 (de) Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
ATE16189T1 (de) Verfahren zur herstellung von menschlichen fetten und von lacto-n-norhexaosyl keramide.
ATE176685T1 (de) Sulfatase-ähnliches protein aus knochen und verfahren zu dessen herstellung
DE69133074T2 (de) Einen basischen Fibroblastwachstumsfaktor enthaltende Mittel zur Behandlung von Knochenkrankheiten
DE60041266D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
MD899G2 (ro) Procedeu de activizare a osteogenezei reparatorii
ATE96303T1 (de) Zubereitung fuer zahnbehandlung und verfahren zur herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee